Brief: UK'S MHRA Grants Marketing Authorisation For AUJEMFLU To Protect Adults Over 50 Against Flu
04/06/2026 17:11
BRIEF-UK'S MHRA Grants Marketing Authorisation For AUJEMFLU To Protect Adults Over 50 Against Flu June 4 (Reuters) - UK's MHRA:
UK'S MHRA: GRANTED MARKETING AUTHORISATION FOR ADJUVANTED TRIVALENT INFLUENZA VACCINE (AUJEMFLU) TO PROTECT ADULTS AGED 50 OVER AGAINST FLU
Further company coverage: CSL.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CSL
See all newsCiti says CSL's CEO pick brings key strengths
Australia's CSL names GSK executive Waterhouse as next CEO (updated)
Brief: CSL Limited Appoints Deborah Waterhouse As CEO And Managing Director
Australia's CSL appoints Deborah Waterhouse as CEO
Early US flu season, current strain may signal risk for younger people; doctors urge shots